Research output per year
Research output per year
Fingerprint
Dive into the research topics where IM-Hem Onc Kidney is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Association of Body Mass Index with the Safety Profile of Nivolumab with or Without Ipilimumab
McQuade, J. L., Hammers, H., Furberg, H., Engert, A., André, T., Blumenschein, G., Tannir, N., Baron, A., Larkin, J., El-Khoueiry, A., Carbone, D. P., Thomas, J. M., Hennicken, D., Coffey, M. & Motzer, R. J., Jan 19 2023, In: JAMA Oncology. 9, 1, p. 102-111 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma
Yin, J., Elias, R., Peng, L., Levonyak, N., Asokan, A., Christie, A., Kubiliun, N., Brugarolas, J. & Hammers, H. J., Jun 2022, In: Clinical Genitourinary Cancer. 20, 3, p. 260-269 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Motzer, R. J., McDermott, D. F., Escudier, B., Burotto, M., Choueiri, T. K., Hammers, H. J., Barthélémy, P., Plimack, E. R., Porta, C., George, S., Powles, T., Donskov, F., Gurney, H., Kollmannsberger, C. K., Grimm, M. O., Barrios, C., Tomita, Y., Castellano, D., Grünwald, V., Rini, B. I., & 5 others, Jun 1 2022, In: Cancer. 128, 11, p. 2085-2097 13 p.Research output: Contribution to journal › Article › peer-review
Open Access47 Scopus citations